Membrane-active peptide PV3 efficiently eradicates multidrug-resistant Pseudomonas aeruginosa in a mouse model of burn infection

The aim of this study was to evaluate the topical bactericidal activity of peptide PV3 against a MDR isolate of Pseudomonas aeruginosa in a mouse model of burn infection. The structural analysis of PV3 by circular dichroism spectroscopy indicated a low peptide helical content in water, whereas a high helical content was observed in the presence of the more hydrophobic 50% (v/v) trifluoroethanol/water buffer. A confocal microscopy analysis indicated that the main action of PV3 occurred at the membrane of bacteria. Peptide PV3 exhibited superior invitro anti-Pseudomonas activity and killing kinetics as compared with doripenem. A single dose of the topically applied peptide PV3 (4 x MBC, 120min) was found to be sufficient to eradicate MDRP.aeruginosa in a bacterially infected mouse burn wound model, whereas doripenem (4 x MBC) failed to eradicate the initial inoculum. This indicates a potent and fast PV3-associated bactericidal activity, contrary to doripenem. An in-depth analysis of mouse skin by histopathology revealed that peptide PV3 (4 x MBC) did not induce any topical skin toxicity. Overall, the data strongly suggest that peptide PV3 might be a potent candidate antimicrobial agent active on antibiotic-resistant isolates of pathogenic bacteria.